--- title: "12 Health Care Stocks Moving In Friday's Pre-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/292319496.md" description: "In Friday's pre-market session, healthcare stocks showed mixed movements. Gainers included VYNE Therapeutics (+17.9%), WORK Medical Tech (+15.34%), and NuCana (+12.09%). Conversely, losers featured SILO Pharma (-22.4%), Virax Biolabs (-18.19%), and Liminatus Pharma (-10.41%). The report highlights specific percentage changes and market caps for these listed companies." datetime: "2026-07-10T12:05:30.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/292319496.md) - [en](https://longbridge.com/en/news/292319496.md) - [zh-HK](https://longbridge.com/zh-HK/news/292319496.md) generator: "portal-rs" --- # 12 Health Care Stocks Moving In Friday's Pre-Market Session ### Gainers - **VYNE Therapeutics** (NASDAQ:VYNE) stock increased by 17.9% to $0.79 during Friday's pre-market session. The company's market cap stands at $22.4 million. - **WORK Medical Tech Gr** (NASDAQ:WOK) shares increased by 15.34% to $2.33. The company's market cap stands at $4.8 million. - **NuCana** (NASDAQ:NCNA) shares increased by 12.09% to $1.39. The company's market cap stands at $5.1 million. - **Pennant Gr** (NASDAQ:PNTG) shares rose 11.22% to $45.0. The company's market cap stands at $1.4 billion. - **Cue Biopharma** (NASDAQ:CUE) stock rose 9.69% to $40.05. The market value of their outstanding shares is at $153.3 million. - **Jin Medical International** (NASDAQ:ZJYL) shares moved upwards by 9.39% to $1.98. The company's market cap stands at $14.1 million. ### Losers - **SILO Pharma** (NASDAQ:SILO) stock declined by 22.4% to $6.0 during Friday's pre-market session. The market value of their outstanding shares is at $8.3 million. - **Virax Biolabs Group** (NASDAQ:VRAX) shares declined by 18.19% to $5.2. The market value of their outstanding shares is at $5.0 million. - **Liminatus Pharma** (NASDAQ:LIMN) shares declined by 10.41% to $0.11. The market value of their outstanding shares is at $7.6 million. - **SciSparc** (NASDAQ:SPRC) shares fell 7.71% to $5.03. The market value of their outstanding shares is at $3.0 million. - **BGM Group** (NASDAQ:BGM) shares declined by 6.89% to $0.32. The market value of their outstanding shares is at $137.3 million. - **GlucoTrack** (NASDAQ:GCTK) stock decreased by 6.88% to $0.36. The market value of their outstanding shares is at $2.4 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [WOK.US](https://longbridge.com/en/quote/WOK.US.md) - [VYNE.US](https://longbridge.com/en/quote/VYNE.US.md) - [SILO.US](https://longbridge.com/en/quote/SILO.US.md) - [LIMN.US](https://longbridge.com/en/quote/LIMN.US.md) - [NCNA.US](https://longbridge.com/en/quote/NCNA.US.md) - [VRAX.US](https://longbridge.com/en/quote/VRAX.US.md) - [YARW.US](https://longbridge.com/en/quote/YARW.US.md) - [PNTG.US](https://longbridge.com/en/quote/PNTG.US.md) - [CUE.US](https://longbridge.com/en/quote/CUE.US.md) - [ZJYL.US](https://longbridge.com/en/quote/ZJYL.US.md) - [SPRC.US](https://longbridge.com/en/quote/SPRC.US.md) - [BGM.US](https://longbridge.com/en/quote/BGM.US.md) - [GCTK.US](https://longbridge.com/en/quote/GCTK.US.md) - [LIMNW.US](https://longbridge.com/en/quote/LIMNW.US.md) ## Related News & Research - [WORK Medical Technology Group reports Q2 results](https://longbridge.com/en/news/296110807.md) - [Silo Pharma says Canada issues notice of allowance for SPC-15 PTSD patent application](https://longbridge.com/en/news/296265804.md) - [Silo Pharma issues 165,000 unregistered shares in asset purchase deal](https://longbridge.com/en/news/296402385.md) - [Congressman Missed Out on Millions by Selling Comfort Systems in 2020 — Now It's the Best Stock of the Last Five Years](https://longbridge.com/en/news/296272826.md) - [Yarrow Bioscience files amended 8-K report on merger exchange ratio update](https://longbridge.com/en/news/295840217.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**